NCT06523114

Transcatheter Arterial Embolization for Elbow and Foot Plantar Pain

Transcatheter Arterial Embolization for Relief of Chronic Musculoskeletal Elbow and Foot Plantar Pain Refractory to Conservative Treatment

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (actual)
• Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine · Academic / Other
• Sex: All
• Age: 19 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This is a prospective single arm study in which patients with moderate to severe chronic elbow or foot plantar pain, in the setting of lateral epicondylitis or plantar fascitis refractory to conservative treatment, will be enrolled. The primary aim of this study is to estimate the effectiveness and safety of transcatheter arterial embolization (TAE) for changes in elbow or plantar pain with 6 and 12-month follow-up.

Detailed description

This is a prospective single arm, single center study at Chung-Ang University Hospital. Patients with moderate to severe elbow or foot pain, and pain refractory to at least 6 months of physician directed conservative therapy (oral analgesic, physical therapy or local injection treatment) will be eligible for enrollment. Transcatheter arterial embolization (TAE) is performed after receiving informed consent, and imipenem is used as an embolic material to embolize the target lesion. After the procedure, evaluate the VAS score and limitation of range of motion (LOM) of the joint area. Follow-up at 1, 3, 6 and 12 months after embolization, and changes of VAS score and LOM are checked.

Conditions

• Elbow Tendinitis
• Elbow Tendinopathy
• Epicondylitis of the Elbow
• Epicondylitis, Lateral
• Plantar Fascitis
• Embolization

Interventions

Type	Name	Description
DEVICE	Transcatheter Arterial Embolization	After accessing the common femoral artery or radial artery, embolization is performed using embolic material after confirming abnormal blood vessel abnormalities, lesion hypervascularity, and lesion enhancement findings.

Timeline

• Start date: 2022-04-18
• Primary completion: 2025-09-02
• Completion: 2025-09-02
• First posted: 2024-07-26
• Last updated: 2025-12-19

Locations

1 site across 1 country: South Korea